Table 3.
Event | Cost ($) | References |
---|---|---|
LVAD implantation | 154,565* | |
LVAD monthly outpatient | 3,187 | 16 |
MM monthly outpatient | 3,515 | 16 |
Living with LVAD > 10 years—annual | 18,377† | |
Living on MM > 10 years—annual | 9,005† | |
Heart transplantation | 154,565* | |
Living after HT—annual | 16,807‡ | |
Stroke | ||
First 90 days | 27,904‡ | |
Follow-up | 19 | |
mRS 0—monthly | 956 | |
mRS 1—monthly | 984 | |
mRS 2—monthly | 1,138 | |
mRS 3—monthly | 1,955 | |
mRS 4—monthly | 3,956 | |
mRS 5—monthly | 5,816* | |
Pump exchange | 154,565* | |
Driveline infection | 13,681‡ | |
GI bleed | 9,990‡ | |
RVAD | 78,676§ | |
Other adverse events | 9,220‡ | |
MM readmission (apart from stroke) | 12,934 | 16 |
All costs were adjusted to reflect 2018 prices either on the IHD platform or using the medical care–specific CPI from the Bureau of Labor Statistics.20
*CMS 2019 DRGs (i.e., 91.5% DRG 001 and 8.5% DRG 002).
†DRG 291 for cost estimation; event rate post 18-month resource use in Smedira.30
‡Medicare claims analysis.
§CMS 2019 DRG 215.
LVAD, left ventricular assist device; MM, medical management; HT, heart transplantation; mRS, modified Rankin Scale; GI, gastrointestinal; RVAD, right ventricular assist device.